Eramet S.a.
ERMAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,933,000 | $3,340,000 | $5,014,000 | $3,710,000 |
| % Growth | -12.2% | -33.4% | 35.1% | – |
| Cost of Goods Sold | $1,219,000 | $1,341,000 | $3,780,000 | $2,906,000 |
| Gross Profit | $1,714,000 | $1,999,000 | $1,234,000 | $762,000 |
| % Margin | 58.4% | 59.9% | 24.6% | 20.5% |
| R&D Expenses | $0 | $0 | $17,000 | $21,000 |
| G&A Expenses | $0 | $0 | $0 | $1,149,000 |
| SG&A Expenses | $0 | $240,000 | -$12,000 | $2,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,663,000 | $1,952,000 | $37,000 | $18,000 |
| Operating Expenses | $1,663,000 | $2,192,000 | $42,000 | $41,000 |
| Operating Income | $51,000 | -$193,000 | $1,025,000 | $879,000 |
| % Margin | 1.7% | -5.8% | 20.4% | 23.7% |
| Other Income/Exp. Net | -$9,000 | $293,000 | $169,000 | $9,000 |
| Pre-Tax Income | $42,000 | $100,000 | $1,194,000 | $888,000 |
| Tax Expense | $94,000 | $88,000 | $264,000 | $98,000 |
| Net Income | $14,000 | $109,000 | $740,000 | $298,000 |
| % Margin | 0.5% | 3.3% | 14.8% | 8% |
| EPS | 0.49 | 3.54 | 25.81 | 10.43 |
| % Growth | -86.2% | -86.3% | 147.5% | – |
| EPS Diluted | 0.49 | 3.77 | 25.48 | 10.39 |
| Weighted Avg Shares Out | 28,472 | 30,791 | 28,675 | 28,572 |
| Weighted Avg Shares Out Dil | 28,472 | 28,942 | 29,037 | 28,692 |
| Supplemental Information | – | – | – | – |
| Interest Income | $49,691 | $39,000 | $10,000 | $9,000 |
| Interest Expense | $201,868 | $159,000 | $116,000 | $114,000 |
| Depreciation & Amortization | $238,000 | $229,000 | $271,000 | $259,000 |
| EBITDA | $469,000 | $244,000 | $1,324,000 | $1,150,000 |
| % Margin | 16% | 7.3% | 26.4% | 31% |